Nidhi Gupta

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Health Insurance

Replacement Therapy

Metastatic Renal Cell Carcinoma

Top Venues

JCO global oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Raina Wadhwa, Nidhi Gupta, Jyoti Dixit, Pankaj Malhotra, Pvm Lakshmi, Shankar Prinja
Cost-Effectiveness Analysis of Denosumab in the Prevention of Skeletal-Related Events Among Patients With Breast Cancer With Bone Metastasis in India. JCO global oncology 10 (2024)
Dharna Gupta, Nidhi Gupta, Navneet Singh, Shankar Prinja
Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India. JCO global oncology 10 (2024)
Dharna Gupta, Nidhi Gupta, Navneet Singh, Shankar Prinja
Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India. JCO global oncology 10 (2024)
Raina Wadhwa, Nidhi Gupta, Jyoti Dixit, Pankaj Malhotra, Pvm Lakshmi, Shankar Prinja
Cost-Effectiveness Analysis of Denosumab in the Prevention of Skeletal-Related Events Among Patients With Breast Cancer With Bone Metastasis in India. JCO global oncology 10 (2024)
Raina Wadhwa, Nidhi Gupta, Jyoti Dixit, Pankaj Malhotra, Pvm Lakshmi, Shankar Prinja
Cost-Effectiveness Analysis of Denosumab in the Prevention of Skeletal-Related Events Among Patients With Breast Cancer With Bone Metastasis in India. JCO global oncology 10 (2024)
Dharna Gupta, Nidhi Gupta, Navneet Singh, Shankar Prinja
Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase- and ROS1 Fusion-Positive Non-Small Cell Lung Cancer in India. JCO global oncology 10 (2024)
Dharna Gupta, Ashish Singh, Nidhi Gupta, Nikita Mehra, Pankaj Bahuguna, Vipul Aggarwal, Manjunath Nookala Krishnamurthy, Partha Sarathi Roy, Pankaj Malhotra, Sudeep Gupta, Lalit Kumar, Amal Kataki, Shankar Prinja
Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India. JCO global oncology 9 (2023)
Dharna Gupta, Ashish Singh, Nidhi Gupta, Nikita Mehra, Pankaj Bahuguna, Vipul Aggarwal, Manjunath Nookala Krishnamurthy, Partha Sarathi Roy, Pankaj Malhotra, Sudeep Gupta, Lalit Kumar, Amal Kataki, Shankar Prinja
Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India. JCO global oncology 9 (2023)
Dharna Gupta, Ashish Singh, Nidhi Gupta, Nikita Mehra, Pankaj Bahuguna, Vipul Aggarwal, Manjunath Nookala Krishnamurthy, Partha Sarathi Roy, Pankaj Malhotra, Sudeep Gupta, Lalit Kumar, Amal Kataki, Shankar Prinja
Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India. JCO global oncology 9 (2023)
Nidhi Gupta, Prerika Nehra, Akashdeep Singh Chauhan, Nikita Mehra, Ashish Singh, Manjunath Nookala Krishnamurthy, Kavitha Rajsekhar, Jayachandran Perumal Kalaiyarasi, Partha Sarathi Roy, Prabhat Singh Malik, Anisha Mathew, Pankaj Malhotra, Amal Chandra Kataki, Jyoti Dixit, Sudeep Gupta, Lalit Kumar, Shankar Prinja
Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India-A Model-Based Economic Analysis. JCO global oncology 8 (2022)
Nidhi Gupta, Akashdeep Singh Chauhan, Shankar Prinja, Awadhesh Kumar Pandey
Impact of COVID-19 on Outcomes for Patients With Cervical Cancer in India. JCO global oncology 7 (2021)